π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
Urolithiasis is one of the most common urological diseases. The risk of uro...
Status
Unknown
Location
Multiple Locations
Start Date
2014-07
Trial ID
NCT02519153
Treatments Being Tested
Low intensity shock waves (LISW) have been proven in animal studies to indu...
Status
Unknown
Location
Rambam Medical Center
Start Date
2010-04
Trial ID
NCT01262157
Treatments Being Tested
The study aims to see how 24 weeks of triple therapy-an endothelin receptor...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-07-01
Trial ID
NCT07266519
Treatments Being Tested
The purpose of this study is to evaluate the correlation between fundus ocu...
Status
Unknown
Location
Ospedale San Raffaele
Start Date
2016-02
Trial ID
NCT02845765
Treatments Being Tested
COMPASS-2 is a Phase 4, prospective, randomized, double-blind, placebo-cont...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00303459
The PEHAB-II study is prospective, randomized trial designed to assess the ...
Status
Recruiting
Location
Canisius Wilhelmina Ziekenhuis
Start Date
2024-01-15
Trial ID
NCT06875258
Treatments Being Tested
This prospective randomized controlled trial (RCT) is designed to provide h...
Status
Recruiting
Location
IRCCS "Regina Elena" National Cancer Institute
Start Date
2023-09-15
Trial ID
NCT06717711
Treatments Being Tested
Erectile dysfunction (ED) has been identified as an independent risk factor...
Status
Completed
Location
Multiple Locations
Start Date
2010-05
Trial ID
NCT01150903
Treatments Being Tested
BAY63-2521 Riociguat leads to the relaxation of smooth muscle cells in pulm...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-18
Trial ID
NCT02007629
Treatments Being Tested
In order to evaluate the effect of CYP3A5\*3 allele on the pharmacokinetics...
Status
Completed
Location
Multiple Locations
Start Date
2007-12
Trial ID
NCT00767598